Kym-001, a First-In-Class Oral Irak4 Protein Degrader, Induces Tumor Regression in Xenograft Models of Myd88-Mutant Abc DLBCL Alone and in Combination With BTK Inhibition
Hematological Oncology - United Kingdom
doi 10.1002/hon.89_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley